MIT featured in U.S. Equity News

NewsGuard 100/100 Score

Micro Identification Technologies, Inc. (OTCBB: MMTC), a leader in rapid bacterial identification, today announces it was recently featured in an editorial published by U.S. Equity News that covers the history of bacteria, its life threatening effects, and publicly traded companies leading the fight against harmful bacteria.

“Although giant pharmaceutical companies remain the biggest players in the war against bacteria, one of the most unique breakthroughs in the science belongs to a little company out of San Clemente, California called Micro Identification Technology ("MIT”

The entire piece can be found at the following link:>

In the editorial U.S. Equity News stated, "Although giant pharmaceutical companies remain the biggest players in the war against bacteria, one of the most unique breakthroughs in the science belongs to a little company out of San Clemente, California called Micro Identification Technology ("MIT"). The company has developed a way to identify 23 different species of pathogenic bacteria, just minutes after completed culturing. It's all done by laser light that is scattered off bacteria cells suspended in water, creating light patterns that are unique for each bacteria species."

Micro Identification's Chief Executive Officer, Michael Brennan, commented on the editorial, "With thousands of people dying each year from harmful bacteria, this article represents the importance of detecting pathogenic bacteria early. We are proud to have been featured in such a prestigious news source."

Mr. Brennan continued, "Our laser-based microbial identification technology makes it possible to rapidly process thousands of samples for pennies on the dollar when compared to the traditional laboratory process; which could effectively save millions in bacterial analysis and healthcare costs. Since our breakthrough method of identification doesn't rely on chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis, we can produce accurate results in a fraction of the time. We are well positioned for immense growth as the knowledge of our technology spreads and hospitals and clinics across the country find new ways to cut costs while still delivering excellent service to their patients."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals skin bacteria removal boosts brain attention signals